Categories: Business

Inventurus Knowledge Solutions Limited Confirms No Impact of New H-1B Visa Fee Changes

BusinessWire India

Mumbai (Maharashtra) [India], September 22: Inventurus Knowledge Solutions Limited (IKS), a leading care enablement platform, has issued a statement to clarify its position regarding the recently announced changes to the H-1B visa fee structure.

IKS confirms that the introduction of the $100,000 fee for new H-1B visa applications has no impact on its business operations or financial projections, as the company does not depend on H-1B visa holders for its workforce.

The strategic business model is centered on delivering high-quality, scalable solutions through a robust delivery framework that combines proprietary technology, a highly skilled workforce in India, and a strong commitment to local hiring in the United States. H-1B visas are not integral to the execution of our core business operations or client service delivery. Consequently, the recent changes have no impact on our ability to serve clients, ensure operational continuity, or pursue our long-term growth objectives.

IKS remains committed to its strategy of driving value for clients through deep domain expertise, technology-led solutions, and a robust global delivery framework. We will continue to monitor developments in the global regulatory landscape and provide updates to our stakeholders as necessary.

(ADVERTORIAL DISCLAIMER: The above press release has been provided by BusinessWire India. ANI will not be responsible in any way for the content of the same)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews syndication

Recent Posts

CHINA PBOC EXPECTED TO SET YUAN MID-POINT AT 6.7177 PER DOLLAR – REUTERS ESTIMATE

CHINA PBOC EXPECTED TO SET YUAN MID-POINT AT 6.7177 PER DOLLAR - REUTERS ESTIMATE (The…

2 minutes ago

Exclusive-Anthropic warns AI may pose 'existential risks to humanity' in IPO filing

By Echo Wang and Aditya Soni Sept 28 (Reuters) - Anthropic plans to caution potential…

3 minutes ago

Exclusive-Anthropic warns AI may pose 'existential risks to humanity' in IPO filing

By Echo Wang and Aditya Soni Sept 28 (Reuters) - Anthropic plans to caution potential…

4 minutes ago

AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination

Sept 29 (Reuters) - HUTCHMED (China) said on Tuesday Anglo-Swedish drugmaker AstraZeneca had filed an…

9 minutes ago

EXCLUSIVE-Anthropic warns AI may pose 'existential risks to humanity' in IPO filing

* Prospectus says models could resist shutdown, conceal information and exhibit behavior resembling blackmail *…

13 minutes ago

Exclusive-Anthropic leaders to control AI lab via 'Founder LLC' to promote public good over market forces

By Echo Wang, Ross Kerber and Jeffrey Dastin Sept 28 (Reuters) - Anthropic has long…

14 minutes ago